Synbio Tech, a leader in probiotic research and development, has achieved a significant milestone with its innovative product, SynForU™-GastroKeep. The company's Lactobacillus plantarum LP23 strain, a crucial component of this functional probiotic, has been granted a Chinese invention patent (Patent No.: ZL 2023 1 0119349.6) for its stomach health benefits.
This breakthrough is the result of collaborative efforts between Synbio Tech's strain research institute and the R&D team in Yangzhou. SynForU™-GastroKeep combines several patented probiotics designed to withstand stomach acid and bile salts, effectively colonize the human stomach, and promote overall digestive health.
In response to the growing global concern of chronic stomach discomfort, often linked to Helicobacter pylori, Synbio Tech has developed SynForU™-GastroKeep as a natural and effective solution. Scientific research suggests that probiotics can inhibit H. pylori growth, balance gut microbiota, and alleviate digestive issues.
Xu Tian-Ken, General Manager of Synbio Tech Yangzhou, emphasized the importance of this patent for the Chinese market. "This recognition not only validates our R&D team's expertise but also strengthens our position as innovators in probiotic technology. It will significantly boost SynForU™-GastroKeep's market presence in China and enhance our brand's competitiveness."
With over two decades of experience in probiotic research, Synbio Tech remains committed to its mission of "changing lives with probiotics." The company plans to increase its investment in the Chinese market, focusing on continuous innovation to meet the growing demand for high-quality stomach health products.
This patent marks another step in Synbio Tech's journey to expand globally while maintaining a strong presence in Taiwan, as it continues to develop superior products that contribute to richer, healthier lives for consumers worldwide.
Reference:
-
1.Shirani, M., Pakzad, R., Haddadi, M. H., Akrami, S., Asadi, A., Kazemian, H., Moradi, M., Kaviar, V. H., Zomorodi, A. R., Khoshnood, S., Shafieian, M., Tavasolian, R., Heidary, M., & Saki, M. (2023). The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC infectious diseases, 23(1), 543.
-
2.Zheng, P. X., Fang, H. Y., Yang, H. B., Tien, N. Y., Wang, M. C., & Wu, J. J. (2016). Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 49(2), 168–174.
- Google Patents. (2023). Lactobacillus plantarum for preventing and assisting in treating stomach deficiency-cold and application thereof. Patent ZL 2023 1 0119349.6. Retrieved from https://patents.google.com/patent/CN116004475A/zh.